reports
- GlobalData Healthcare Department
Kamada Ltd (KMDA) - Financial Analysis Review
Kamada Ltd (KMDA) - Financial Analysis Review Summary Kamada Ltd (Kamada) is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific Immunoglobulins and other prescription medicines. The company’s flagship product includes, glassia, a intravenous plasma-derived alpha-1 antitrypsin (AAT) product which is used for the treatment of patients with emphysema secondary to congenital AAT deficiency. It also offers products for the treatment of cystic fibrosis...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.